Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00616798
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Condition: Schizophrenia
Interventions: Drug: RO4917838;   Drug: Placebo;   Drug: Standard antipsychotic therapy

Indicates status has not been verified in more than two years